Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
In this study, the safety and pharmacokinetics of 10 % terbinafine hydrogen chloride (HCl)
nail lacquer wre investigated by comparison with vehicle control and 1% terbinafine cream
Phase:
Phase 1
Details
Lead Sponsor:
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)